UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study

Diabetes technology & therapeutics, 2021-03, Vol.23 (3), p.203

2021

Volltextzugriff (PDF)

Changes in Basal Insulin Infusion Rates With Subcutaneous Insulin Infusion: Time until a change in metabolic effect is induced in patients with type 1 diabetes

Diabetes care, 2009-08, Vol.32 (8), p.1437-1439

2009

Volltextzugriff (PDF)

Changes in Basal Insulin Infusion Rates With Subcutaneous Insulin Infusion

Diabetes care, 2009-08, Vol.32 (8), p.1437-1439

2009

Volltextzugriff (PDF)

1043-P: GoBolus Study: Impact of Faster Aspart on Glycemic Control in a Real-World Population with Type 1 Diabetes on Basal-Bolus Therapy as Multiple Daily Injections Using Flash Glucose Monitoring

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

Annals of internal medicine, 2003-06, Vol.138 (12), p.952

2003

Volltextzugriff (PDF)

Results that matter: Structured vs. unstructured self-monitoring of blood glucose in type 2 diabetes

Diabetes research and clinical practice, 2012-07, Vol.97 (1), p.6-15

2012

Volltextzugriff (PDF)

A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study

Diabetes technology & therapeutics, 2011-08, Vol.13 (8), p.797

2011

Volltextzugriff (PDF)

Diabetes Data Management System to Improve Glycemic Control in People With Type 1 Diabetes: Prospective Cohort Study

JMIR mHealth and uHealth, 2017-11, Vol.5 (11), p.e170-e170

2017

Volltextzugriff (PDF)

Use of an Automated Decision Support Tool Optimizes Clinicians’ Ability to Interpret and Appropriately Respond to Structured Self-Monitoring of Blood Glucose Data

Diabetes care, 2012-04, Vol.35 (4), p.693-698

2012

Volltextzugriff (PDF)

Use of an automated decision support tool optimizes clinicians' ability to interpret and appropriately respond to structured self-monitoring of blood glucose data

Diabetes care, 2012-04, Vol.35 (4), p.693-698

2012

Volltextzugriff (PDF)

Introduction of Insulin Glargine to Basal-Bolus Therapy Improves Metabolic Control in Patients with Type 1 Diabetes in Everyday Clinical Practice

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A518

2005

Volltextzugriff (PDF)

The Efficacy of Long-Term Insulin Glargine and Oral Antidiabetic Therapy in Patients with Type 2 Diabetes

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A143

2005

Volltextzugriff (PDF)

Good Glycemic Control With Flexibility in Timing of Basal Insulin Supply: A 24-week comparison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride

Diabetes care, 2005-02, Vol.28 (2), p.419-420

2005

Volltextzugriff (PDF)

Introduction of Insulin Glargine to Basal-Bolus Therapy Improves Metabolic Control in Patients with Type 2 Diabetes in Everyday Clinical Practice

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A518

2005

Volltextzugriff (PDF)

Patients with Type 2 Diabetes Inadequately Controlled on Premixed Insulin: Effect of Initiating Insulin Glargine Plus Oral Agents on Glycemic Control in Daily Practice

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A518

2005

Volltextzugriff (PDF)

The Role of Titration Enforcement for the Treat-to-Target Concept with Add-On Insulin Therapy in Patients with Type 2 Diabetes

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A144

2005

Volltextzugriff (PDF)

HbA^sub 1c^ Levels below 7% Can Be Achieved by an Add-On Insulin Therapy in Patients with Type 2 Diabetes: The APOLLO Trial

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A519

2005

Volltextzugriff (PDF)

Comparison of Continuous Blood Glucose Measurement with Conventional Documentation of Hypoglycemia in Patients with Type 2 Diabetes on Multiple Daily Insulin Injection Therapy

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A492

2005

Volltextzugriff (PDF)

Insulin Glargine Improves Glycemic Control in Patients with Type 2 Diabetes on Multiple Daily Insulin Injections Confirmed by Using the CGMS

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A492

2005

Volltextzugriff (PDF)

Treatment Satisfaction with a Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin Alone in Patients with Type 2 Diabetes

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A304

2005

Volltextzugriff (PDF)

The Impact of Insulin Glargine on Lifestyle Flexibility in Patients with Type 1 Diabetes

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A145

2005

Volltextzugriff (PDF)

Good Glycemic Control With Flexibility in Timing of Basal Insulin Supply

Diabetes care, 2005-02, Vol.28 (2), p.419-420

2005

Volltextzugriff (PDF)

Insulin combination therapy in type 2 diabetes mellitus

Annals of internal medicine, 2004-04, Vol.140 (8), p.666; author reply 667

2004

Volltextzugriff (PDF)

Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease

Zeitschrift fur Gastroenterologie, 2021-11, Vol.59 (11), p.1189

2021

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(24)

Sprache

Englisch
(23)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(9)
Diabetes
(6)
Endocrinology & Metabolism
(6)
Male
(6)
Middle Aged
(6)
Female
(5)
Diabetes Mellitus, Type 2 - Blood
(4)
Insulin
(4)
Adult
(3)
Aged
(3)
Biological And Medical Sciences
(3)
Blood Glucose - Metabolism
(3)
Blood Glucose Self-Monitoring - Methods
(3)
Care And Treatment
(3)
Clinical Medicine
(3)
Diabetes Mellitus, Type 2 - Drug Therapy
(3)
Diagnosis
(3)
Glycated Hemoglobin A - Metabolism
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes
(11)
Diabetes Care
(6)
Annals Of Internal Medicine
(2)
Diabetes Technology & Therapeutics
(2)
Diabetes Research And Clinical Practice
(1)
Jmir Mhealth And Uhealth
(1)
Zeitschrift Fur Gastroenterologie
(1)
Zeitschrift Für Gastroenterologie
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study

Changes in Basal Insulin Infusion Rates With Subcutaneous Insulin Infusion: Time until a change in metabolic effect is induced in patients with type 1 diabetes

Changes in Basal Insulin Infusion Rates With Subcutaneous Insulin Infusion

1043-P: GoBolus Study: Impact of Faster Aspart on Glycemic Control in a Real-World Population with Type 1 Diabetes on Basal-Bolus Therapy as Multiple Daily Injections Using Flash Glucose Monitoring

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

Results that matter: Structured vs. unstructured self-monitoring of blood glucose in type 2 diabetes

A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study

Diabetes Data Management System to Improve Glycemic Control in People With Type 1 Diabetes: Prospective Cohort Study

Use of an Automated Decision Support Tool Optimizes Clinicians’ Ability to Interpret and Appropriately Respond to Structured Self-Monitoring of Blood Glucose Data

Use of an automated decision support tool optimizes clinicians' ability to interpret and appropriately respond to structured self-monitoring of blood glucose data

Introduction of Insulin Glargine to Basal-Bolus Therapy Improves Metabolic Control in Patients with Type 1 Diabetes in Everyday Clinical Practice

The Efficacy of Long-Term Insulin Glargine and Oral Antidiabetic Therapy in Patients with Type 2 Diabetes

Good Glycemic Control With Flexibility in Timing of Basal Insulin Supply: A 24-week comparison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride

Introduction of Insulin Glargine to Basal-Bolus Therapy Improves Metabolic Control in Patients with Type 2 Diabetes in Everyday Clinical Practice

Patients with Type 2 Diabetes Inadequately Controlled on Premixed Insulin: Effect of Initiating Insulin Glargine Plus Oral Agents on Glycemic Control in Daily Practice

The Role of Titration Enforcement for the Treat-to-Target Concept with Add-On Insulin Therapy in Patients with Type 2 Diabetes

HbA^sub 1c^ Levels below 7% Can Be Achieved by an Add-On Insulin Therapy in Patients with Type 2 Diabetes: The APOLLO Trial

Comparison of Continuous Blood Glucose Measurement with Conventional Documentation of Hypoglycemia in Patients with Type 2 Diabetes on Multiple Daily Insulin Injection Therapy

Insulin Glargine Improves Glycemic Control in Patients with Type 2 Diabetes on Multiple Daily Insulin Injections Confirmed by Using the CGMS

Treatment Satisfaction with a Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin Alone in Patients with Type 2 Diabetes

The Impact of Insulin Glargine on Lifestyle Flexibility in Patients with Type 1 Diabetes

Good Glycemic Control With Flexibility in Timing of Basal Insulin Supply

Insulin combination therapy in type 2 diabetes mellitus

Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease

Suchergebnisse filtern